Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus isoflurane for bleeding during endoscopic sinus surgery
IRCT20120801010471N3Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Nov 2016
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in paranasal sinus disease comparing Sevoflurane group with Isoflurane group (2 arms). Primary endpoint: Bleeding rate during endoscopic nasal sinus surgery. Started Nov 2016; status: completed.
02
Drugs
sevofluraneisoflurane
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on IRCT20120801010471N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120801010471N3.